A novel prognostic nomogram for adult acute lymphoblastic leukemia: a comprehensive analysis of 321 patients

[1]  P. Jia,et al.  Novel gene signature reveals prognostic model in acute lymphoblastic leukemia , 2022, Frontiers in Cell and Developmental Biology.

[2]  Yanfang Liu,et al.  An easy-to-use nomogram predicting overall survival of adult acute lymphoblastic leukemia , 2022, Frontiers in Oncology.

[3]  N. Liao,et al.  A Nomogram for Predicting Event-Free Survival in Childhood Acute Lymphoblastic Leukemia: A Multicenter Retrospective Study , 2022, Frontiers in Oncology.

[4]  Depei Wu,et al.  Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy , 2022, Frontiers in Immunology.

[5]  M. Konopleva,et al.  Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience , 2021, Blood advances.

[6]  Mustafa Jahangoshai Rezaee,et al.  Analysis and decision based on specialist self-assessment for prognosis factors of acute leukemia integrating data-driven Bayesian network and fuzzy cognitive map , 2020, Medical & Biological Engineering & Computing.

[7]  F. Du,et al.  Prognostic Nomogram for Childhood Acute Lymphoblastic Leukemia: A Comprehensive Analysis of 673 Patients , 2020, Frontiers in Oncology.

[8]  Jianmin Yang,et al.  Dynamic prediction of relapse in patients with acute leukemias after allogeneic transplantation: Joint model for minimal residual disease , 2020, International journal of laboratory hematology.

[9]  Yan Tang,et al.  A Nomogram for the Prediction of Progression and Overall Survival in Childhood Acute Lymphoblastic Leukemia , 2020, Frontiers in Oncology.

[10]  Nan Zhang,et al.  Development of an immune‐related prognostic model for pediatric acute lymphoblastic leukemia patients , 2020, Molecular genetics & genomic medicine.

[11]  K. Ballen,et al.  MLL-Rearranged Acute Lymphoblastic Leukemia , 2020, Current Hematologic Malignancy Reports.

[12]  A. Zelenetz,et al.  Acute lymphoblastic leukemia. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[13]  H. Dombret,et al.  Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia , 2019, Leukemia & lymphoma.

[14]  T. Greene,et al.  A simple method to estimate the time-dependent receiver operating characteristic curve and the area under the curve with right censored data , 2018, Statistical methods in medical research.

[15]  Patrick W. Burke,et al.  NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.

[16]  M. Geyer,et al.  Overall survival among older US adults with ALL remains low despite modest improvement since 1980: SEER analysis. , 2017, Blood.

[17]  中国成人急性淋巴细胞白血病诊断与治疗指南(2016年版) , 2016, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[18]  L. Silverman,et al.  Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances , 2016, Current Hematologic Malignancy Reports.

[19]  M. Czuczman,et al.  Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody‐dependent cytotoxicity and improves overall survival against CD20+ rituximab‐sensitive/‐resistant Burkitt lymphoma (BL) and precursor B‐acute lymphoblastic leukaemia (pre‐B‐ALL): potential targeted therapy in p , 2015, British journal of haematology.

[20]  Huanhuan Sun,et al.  Survival improvement by decade of patients aged 0–14 years with acute lymphoblastic leukemia: a SEER analysis , 2014, Scientific Reports.

[21]  H. Brenner,et al.  Survival of Adults with Acute Lymphoblastic Leukemia in Germany and the United States , 2014, PloS one.

[22]  Wendy K. Jo,et al.  Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations. , 2013, Cancer genetics.

[23]  P. Kufer,et al.  Blinatumomab: a historical perspective. , 2012, Pharmacology & therapeutics.

[24]  M. Tallman,et al.  Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial , 2012, British journal of haematology.

[25]  D. Hoelzer,et al.  Modern therapy of acute lymphoblastic leukemia. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  W. Stock.  Adolescents and young adults with acute lymphoblastic leukemia. , 2010, Hematology. American Society of Hematology. Education Program.

[27]  S. Altekruse,et al.  Outcomes for children and adolescents with cancer: challenges for the twenty-first century. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  S. Richards,et al.  Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. , 2010, The Lancet. Oncology.

[29]  N. Heerema,et al.  Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  H. Brenner,et al.  Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. , 2009, Blood.

[31]  M. Loh,et al.  Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG). , 2007, Blood.

[32]  E. Elkin,et al.  Decision Curve Analysis: A Novel Method for Evaluating Prediction Models , 2006, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  C. Sternberg,et al.  Are nomograms better than currently available stage groupings for bladder cancer? , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  H. Kantarjian,et al.  Adult acute lymphoblastic leukemia. , 2005, Mayo Clinic proceedings.

[35]  M. Kattan,et al.  Validation and adaptation of a nomogram for predicting the survival of patients with extremity soft tissue sarcoma using a three‐grade system , 2005, Cancer.

[36]  H. Kantarjian,et al.  Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemia , 2004, Cancer.

[37]  W. Hofmann,et al.  Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  C. Pui,et al.  Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements , 2003, Leukemia.

[39]  A. Baruchel,et al.  Prognostic study of continuous variables (white blood cell count, peripheral blast cell count, haemoglobin level, platelet count and age) in childhood acute lymphoblastic leukaemia. Analysis of a population of 1545 children treated by the French Acute Lymphoblastic Leukaemia Group (FRALLE) , 2000, British Journal of Cancer.

[40]  D. Hoelzer,et al.  Treatment of adult acute lymphoblastic leukemia. , 1999, Hematology. American Society of Hematology. Education Program.

[41]  P. Grambsch,et al.  Proportional hazards tests and diagnostics based on weighted residuals , 1994 .

[42]  Michael L. Cleary,et al.  Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukemias , 1992, Cell.

[43]  H. Alder,et al.  The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene , 1992, Cell.

[44]  A. Younes,et al.  Novel immunotherapies in lymphoid malignancies , 2016, Nature Reviews Clinical Oncology.

[45]  A. Moorman,et al.  A population-based cytogenetic study of adults with acute lymphoblastic leukemia. , 2010, Blood.

[46]  J. Downing,et al.  Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. , 2010, Blood.

[47]  Michael W Kattan,et al.  Prediction of seminal vesicle invasion in prostate cancer: incremental value of adding endorectal MR imaging to the Kattan nomogram. , 2007, Radiology.

[48]  L. J,et al.  Rearrangement of the MLL Gene Confers a Poor Prognosis in Childhood Acute Lymphoblastic Leukemia , Regardless of Presenting Age , 2002 .

[49]  Ganser,et al.  Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. , 1988, Blood.